Litcius/Paper detail

Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma

Shuai Wu, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu, Nail Fatkhutdinov, Joseph A. Zundell, Sergey Karakashev, Wei Zhou, Lauren E. Schwartz, Hsin‐Yao Tang, Ronny Drapkin, Qin Liu, David G. Huntsman, Andrew V. Kossenkov, David W. Speicher, Zachary T. Schug, Chi V. Dang, Rugang Zhang

2021Nature Cancer125 citationsDOIOpen Access PDF

Topics & Concepts

GlutamineCancer researchOvarian carcinomaChemistryARID1AOvarian cancerBiologyBiochemistryCancerMutationGeneGeneticsAmino acidChromatin Remodeling and CancerNeuroendocrine Tumor Research AdvancesCancer Mechanisms and Therapy
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma | Litcius